NAMI
OCUL icon

Nomura Asset Management International’s Ocular Therapeutix OCUL Stock Holding History

Nomura Asset Management International’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.44M Buy
248,048
+13,501
+6% +$122K ﹤0.01% 1029
2026
Q1 		$1.99M Buy
234,547
+74,801
+47% +$713K ﹤0.01% 972
2025
Q4 		$1.94M Buy
+159,746
New +$1.94M ﹤0.01% 998

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nomura Asset Management International's OCUL Position: Q2 2026 in Review

Nomura Asset Management International increased its Ocular Therapeutix (OCUL) stake by 5.8% in Q2 2026, buying an estimated $122K and bringing the position to 248,048 shares worth $2.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1029.

Nomura Asset Management International first reported a position in OCUL in Q4 2025 and has held it in 3 quarters since. 261 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Nomura Asset Management International held 248,048 shares of Ocular Therapeutix worth $2.44M as of Q2 2026.
  • Nomura Asset Management International bought 13,501 Ocular Therapeutix shares in Q2 2026, an estimated $122K.
  • Ocular Therapeutix made up ﹤0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #1029 holding.
  • Nomura Asset Management International first reported a position in Ocular Therapeutix in Q4 2025 and has held it in 3 quarters since.
  • 261 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.